Month: April 2024
2065 posts
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 – A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) – and Upcoming Scientific Presentations
SAN FRANCISCO and SUZHOU, China, April 30, 2024 /PRNewswire/ — Eluminex Biosciences (Eluminex), a…